Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06192199

The Diagnostic Value of APTT/Fibrinogen Ratio in Pulmonary Embolism

Status
Recruiting
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

From January 1, 2023 to December 30, 2023, patients who were suspected of pulmonary embolism and underwent CTPA examination at Nanyang Hospital of Southern Medical University were divided into pulmonary embolism group and non pulmonary embolism group. 1. Collect relevant data, including gender, age, primary disease, CTPA imaging and reports, BNP, troponin, electrocardiogram, cardiac ultrasound, PT, APTT, TT, fibrinogen, D-dimer, etc., and analyze demographic data, pulmonary embolism risk grading, APTT/fibrinogen ratio, and determine their cut-off values through statistical analysis of the two groups. 2. Follow up on the APTT/fibrinogen ratio after anticoagulation treatment and bleeding in the pulmonary embolism group.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST2018 edition of the Guidelines for DiagnosisAccording to the 2018 edition of the Guidelines for Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism, and based on inclusion and exclusion criteria, enrolled patients were divided into a pulmonary embolism group and a non pulmonary embolism group

Timeline

Start date
2018-01-01
Primary completion
2025-05-01
Completion
2026-12-01
First posted
2024-01-05
Last updated
2025-04-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06192199. Inclusion in this directory is not an endorsement.